A prevention program for binge drinking among students based on mindfulness and implementation intention (ALCOMEDIIT): a randomized controlled trial.

Journal Information

Full Title: Trials

Abbreviation: Trials

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the details of the questions integrated in the mobile application are available on osf: https://osf io/3n4c6/ .; the two systematic phases related to an ii process are specific to each of the two implementations (all details available on osf: https://osf io/3n4c6/ .; all details of the statistical analysis plan (sap) are included in a supplementary file available online ( https://osf io/3n4c6/files/osfstorage ).; nevertheless once collected the datasets generated and/or analyzed during the current study are available in the open science framework on: https://osf io/3n4c6/ . availability of data and materials as it is a study protocol publication data are not yet available. nevertheless once collected the datasets generated and/or analyzed during the current study are available in the open science framework"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe experimental protocol was approved by the ethics committee CHU Caen Normandie (Centre Hospitalier Universitaire; University Hospital Center) following a national evaluation procedure by the National French Ethics Commitee (Comité de Protection des Personnes; CPP). The authorization identification number (No. ID-RCB) is coded: 2022-A00983-40.Informed consent was validated by the French ethics committee. The informed consent was obtained and will be obtained (recruitment in progress), from all subjects and/or their legal guardian(s). Consent for publicationConsent for publication was included in the consent form presented to participants. Competing interestsThe authors declare that they have no competing interests Competing interests The authors declare that they have no competing interests"

Evidence found in paper:

"Funding The work reported was supported by RIN Tremplin Grant 19E00906 of Normandie Région, France, and mainly by IReSP and the Aviesan Alliance as part of the call for research projects to combat addiction to psychoactive substances Grant IRESP-19-ADDICTIONS-03. Funders have no role in the collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication."

Evidence found in paper:

"Trial registration ClinicalTrials.gov Identifier: NCT05565989, September 30, 2022. https://clinicaltrials.gov/study/NCT05565989 Protocol version 2.0 (September 2022) No. ID-RCB : 2022-A00983-40"

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025